Literature DB >> 24832014

Trends in hepatitis C virus infections among MSM attending a sexually transmitted infection clinic; 1995-2010.

Anouk T Urbanus1, Thijs J W Van De Laar, Ronald Geskus, Joost W Vanhommerig, Martijn S Van Rooijen, Janke Schinkel, Titia Heijman, Roel A Coutinho, Maria Prins.   

Abstract

BACKGROUND: Since 2000, there is growing evidence that hepatitis C virus (HCV) infection has emerged as a sexually transmitted infection (STI) among HIV-positive MSM. Here, we present a 15-year overview of the HCV epidemic among MSM visiting a large STI-clinic in the Netherlands.
METHODS: During biannual cross-sectional anonymous surveys (1995-2010), participants were interviewed and tested for HIV and HCV-antibodies. Additional HCV RNA tests were performed in all HIV-positives. Determinants of HCV infection were analysed using logistic regression. Phylogenetic analysis provided evidence for sexual transmission.
RESULTS: HCV prevalence among HIV-positive MSM increased from 1995 onwards (5.6%) and peaked in 2008 (20.9%). Prevalent HCV infection was more strongly associated with fisting in 2007-2008 [adjusted odds ratio (aOR) 2.85, 95% confidence interval (CI) 1.19-6.82] than in 2009-2010 (aOR 0.92, 95% CI0.42-2.02). In addition, HCV infection was independently associated with Chlamydia, injecting drug use, unprotected anal intercourse and older age. Phylogenetic analysis revealed a high degree of MSM-specific clustering from 2000 onwards. Identification of a new MSM-specific HCV lineage and the finding of recent HCV infections (0-4%) in established HCV clusters during recent years argue for ongoing transmission of HCV among HIV-positive MSM. HCV prevalence among HIV-negative MSM remained low (2007-2010: 0.5%).
CONCLUSION: HCV prevalence among HIV-positive MSM significantly increased over calendar time but appears to level off in recent years, possibly due to increased awareness, saturation in the population, decreased risk behaviour and earlier HCV screening and treatment. The association with fisting became less strong over time, but our analyses continue to support sexual transmission. Monitoring HIV-positive and HIV-negative MSM for HCV infection remains needed to guide prevention efforts.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24832014     DOI: 10.1097/QAD.0000000000000126

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  21 in total

Review 1.  Acute HCV in HIV-infected MSM: modes of acquisition, liver fibrosis, and treatment.

Authors:  Emma Kaplan-Lewis; Daniel Seth Fierer
Journal:  Curr HIV/AIDS Rep       Date:  2015-09       Impact factor: 5.071

Review 2.  Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antivirals.

Authors:  Nicola Coppola; Mariantonietta Pisaturo; Rosa Zampino; Margherita Macera; Caterina Sagnelli; Evangelista Sagnelli
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

Review 3.  Incidence of hepatitis C in HIV positive and negative men who have sex with men 2000-2016: a systematic review and meta-analysis.

Authors:  Virginia Ghisla; Alexandra U Scherrer; Dunja Nicca; Dominique L Braun; Jan S Fehr
Journal:  Infection       Date:  2016-12-22       Impact factor: 3.553

4.  Prevalence and Phylogenetic Characterization of Hepatitis C Virus Among Indian Men Who Have Sex With Men: Limited Evidence for Sexual Transmission.

Authors:  Steven J Clipman; Priya Duggal; Aylur K Srikrishnan; Shanmugam Saravanan; Pachamuthu Balakrishnan; Canjeevaran K Vasudevan; David D Celentano; David L Thomas; Shruti H Mehta; Sunil S Solomon
Journal:  J Infect Dis       Date:  2020-05-11       Impact factor: 5.226

Review 5.  Enhancing our understanding of current therapies for hepatitis C virus (HCV).

Authors:  Neliswa A Gogela; Ming V Lin; Jessica L Wisocky; Raymond T Chung
Journal:  Curr HIV/AIDS Rep       Date:  2015-03       Impact factor: 5.071

Review 6.  Epidemiology of hepatitis C in Croatia in the European context.

Authors:  Tatjana Vilibic-Cavlek; Jasmina Kucinar; Bernard Kaic; Maja Vilibic; Nenad Pandak; Ljubo Barbic; Vladimir Stevanovic; Jasmina Vranes
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

Review 7.  Pre-exposure prophylaxis for MSM and transgender persons in early adopting countries.

Authors:  Elske Hoornenborg; Douglas S Krakower; Maria Prins; Kenneth H Mayer
Journal:  AIDS       Date:  2017-10-23       Impact factor: 4.177

8.  Effect of incident hepatitis C infection on CD4+ cell count and HIV RNA trajectories based on a multinational HIV seroconversion cohort.

Authors:  Daniela K van Santen; Jannie J van der Helm; Giota Touloumi; Nikos Pantazis; Roberto Muga; Barbara Gunsenheimer-Bartmeyer; M John Gill; Eduard Sanders; Anthony Kelleher; Robert Zangerle; Kholoud Porter; Maria Prins; Ronald B Geskus
Journal:  AIDS       Date:  2019-02-01       Impact factor: 4.177

9.  Prevalence and Risk Factors of HCV/HIV Co-Infection and HCV Genotype Distribution in North-Eastern Poland.

Authors:  Anna Grzeszczuk; Alicja Danuta Wandalowicz; Jerzy Jaroszewicz; Robert Flisiak
Journal:  Hepat Mon       Date:  2015-07-22       Impact factor: 0.660

Review 10.  Role of Serologic and Molecular Diagnostic Assays in Identification and Management of Hepatitis C Virus Infection.

Authors:  Gavin Cloherty; Andrew Talal; Kelly Coller; Corklin Steinhart; John Hackett; George Dawson; Juergen Rockstroh; Jordan Feld
Journal:  J Clin Microbiol       Date:  2015-12-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.